Lewis Sanders
Sanders Capital
Lewis Sanders Humana Inc stake
total: 132
Sanders Capital HUM trades
- Total transactions:
- 7
- New positions:
- 1
- Sold out:
- 1
- Added:
- 4
- Reduced:
- 1
- Held since:
- 2023 Q4
- Held for:
- 6 quarters
- Latest activity:
- 2025 Q2
According to 2026 Q2 report, Lewis Sanders doesn't hold any Humana Inc (HUM) shares. To date, the estimated cost basis is nearly $444.61 for "buy" trades and estimated average "sell" price is $264.6. Sanders Capital first purchased HUM in 2023 Q4, initially acquiring about 1.07M shares. Since the initial investment in Humana Inc (HUM), Sanders Capital has made 6 more transactions.
When did Lewis Sanders sell Humana Inc (HUM)?
Lewis Sanders sold off the entire Humana Inc (HUM) position in 2025 Q2.
When did Lewis Sanders buy Humana Inc (HUM)?
Lewis Sanders first invested in Humana Inc (HUM) in 2023 Q4 at the reported quarter-end price of $457.81 per share.
What's the cost basis of Sanders Capital's HUM stake?
The estimated cost basis for Humana Inc (HUM) stake is around $444.61 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $444.61
- Weighted AVG sell price:
- $264.60
Lewis Sanders's historical trades in Humana Inc
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2025 Q2
|
0.00%
|
0
|
$264.60
|
|
-100% (-1,191,951)
|
-0.47%
|
|
2025 Q1
|
0.47%
|
1,191,951
|
$264.60
|
$315,390,235
|
-0.23% (-2,757)
|
-0%
|
|
2024 Q4
|
0.44%
|
1,194,708
|
$253.71
|
$303,109,367
|
+2.26% (+26,367)
|
+0.01%
|
|
2024 Q3
|
0.54%
|
1,168,341
|
$316.74
|
$370,060,328
|
+1.03% (+11,923)
|
+0.01%
|
|
2024 Q2
|
0.66%
|
1,156,418
|
$373.65
|
$432,095,586
|
+3.42% (+38,189)
|
+0.02%
|
|
2024 Q1
|
0.65%
|
1,118,229
|
$346.72
|
$387,712,359
|
+4.63% (+49,446)
|
+0.03%
|
|
2023 Q4
|
0.90%
|
1,068,783
|
$457.81
|
$489,299,545
|
new
|
+0.9%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.